Helix CBD Therapy Cream recalled over manufacturing violations
- Recall date
- August 2, 2023
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Parker Laboratories, Inc. recalls Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-…
- Recall number
- D-1092-2023
- FDA classification
- Class II
- Brand / firm
- Parker Laboratories, Inc.
- Sold / distributed
- Nationwide within the United States, Singapore, Korea and Hong Kong
Why it was recalled
CGMP Deviations
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Helix CBD Therapy Cream (Menthol 7.4%), packaged in a) 3 g pouch (NDC 30775-053-01), b) 2 fl. oz. tubes (NDC 30775-053-02), c) 4 fl. oz. tubes (NDC 30775-053-04), Parker Laboratories Inc., Fairfield, NJ, 07004
Get recall alerts
Free email alert whenever Parker Laboratories, Inc. has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Parker Laboratories, Inc.